ERBB2 and ovarian carcinoma: 124I-labeled C6.5 diabody, a small-engineered antibody fragment that is specific for the HER2 receptor tyrosine kinase, was investigated by using SCID mice bearing HER2-positive human ovarian carcinoma (SK-OV-3) xenografts.